These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2894439)

  • 21. Intra-arterial pharmacokinetics and pulmonary first-pass of levamisole in rabbits.
    Pereda P; García JJ; Sierra M; Fernández N; Sahagun AM; Diez MJ
    Pharmacol Res; 2002 Apr; 45(4):285-9. PubMed ID: 12030791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol.
    Buttar HS; Moffatt JH; Bura C
    J Toxicol Environ Health; 1988; 24(1):1-18. PubMed ID: 3373560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.
    de Leede LG; de Boer AG; Havermans JP; Breimer DD
    Pharm Res; 1984 Jul; 1(4):164-8. PubMed ID: 24277285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma propranolol levels in beagle dogs after administration of propranolol hemisuccinate ester.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Oct; 67(10):1360-3. PubMed ID: 702279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol uptake with high capacity by rat perfused lung.
    Iwamoto K; Watanabe J; Yonekawa H
    J Pharm Pharmacol; 1988 Jun; 40(6):445-7. PubMed ID: 2901480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Route dependent pulmonary first-pass metabolism of a series of biphenylacetic acid esters in rats.
    Dickinson PA; Taylor G
    Eur J Pharm Sci; 1998 Jan; 6(1):11-8. PubMed ID: 16256703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.
    Lee HJ; Chiou WL
    Pharm Res; 1989 Oct; 6(10):840-3. PubMed ID: 2608625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects.
    Walle T; Walle UK; Cowart TD; Conradi EC
    Clin Pharmacol Ther; 1989 Sep; 46(3):257-63. PubMed ID: 2776391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma propranolol before, during, and after cardiopulmonary bypass.
    Plachetka JR; Salomon NW; Copeland JG
    Clin Pharmacol Ther; 1981 Dec; 30(6):745-51. PubMed ID: 7307425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.
    Okabe H; Mizukami A; Taguchi M; Aiba T; Yasuhara M; Hashimoto Y
    J Pharm Pharmacol; 2003 Apr; 55(4):479-86. PubMed ID: 12803769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide induced sinusoidal relaxation after a propranolol priming dose in the perfused rat liver reduces propranolol availability on subsequent dosing.
    Liu X; Zou Y; Khlentzos AM; Yang Y; Nikolovski J; Weiss M; Roberts MS
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1028-33. PubMed ID: 20659130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ageing on the hepatic clearance of propranolol.
    Castleden CM; George CF
    Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of propranolol: a review.
    Shand DG
    Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.